title: The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome.
abstract: CpG oligodeoxynucleotides (CpG ODN) are known to be a potent immunoadjuvant for a wide range of antigens. The aim of this study was to evaluate the role of CpG ODN co-encapsulated with rgp63 antigen in cationic liposomes (Lip-rgp63-CpG ODN) in immune response enhancement and protection in BALB/c mice against leishmaniasis. Lip-rgp63-CpG ODN prepared by using dehydration-rehydration vesicle (DRV) method significantly inhibited (P<0.001) Leishmania major infection in mice measured by footpad swelling compared to Lip-rgp63, rgp63 alone, rgp63 plus CpG ODN, PBS or control liposomes. The mice immunized with Lip-rgp63-CpG ODN also showed the lowest spleen parasite burden, highest IgG2a/IgG1 ratio and IFN-gamma production and the lowest IL-4 production compared to the other groups. The results indicate that co-encapsulation of CpG ODN in liposomes improves the immunogenicity of Leishmania antigen.
authors.affiliation: School of Pharmacy, Biotechnology Research Center and Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. mr_jaafari@yahoo.com
authors.forename: Mahmoud R
authors.initials: MR
authors.lastname: Jaafari
authors.forename: Ali
authors.initials: A
authors.lastname: Badiee
authors.forename: Ali
authors.initials: A
authors.lastname: Khamesipour
authors.forename: Afshin
authors.initials: A
authors.lastname: Samiei
authors.forename: Dina
authors.initials: D
authors.lastname: Soroush
authors.forename: Masoumeh Tavassoti
authors.initials: MT
authors.lastname: Kheiri
authors.forename: Farzaneh
authors.initials: F
authors.lastname: Barkhordari
authors.forename: W Robert
authors.initials: WR
authors.lastname: McMaster
authors.forename: Fereidoun
authors.initials: F
authors.lastname: Mahboudi
mesh_terms: D000276:Adjuvants, Immunologic; D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D000953:Antigens, Protozoan / Q000235:genetics / Q000276:immunology*; D002412:Cations / Q000737:chemistry; D002478:Cells, Cultured; D018899:CpG Islands / Q000276:immunology*; D016207:Cytokines / Q000378:metabolism; D005260:Female; D005786:Gene Expression Regulation; D007074:Immunoglobulin G / Q000097:blood; D007891:Leishmania / Q000276:immunology*; D007896:Leishmaniasis / Q000517:prevention & control; D008081:Liposomes / Q000737:chemistry; D008666:Metalloendopeptidases / Q000235:genetics / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D016052:Protozoan Vaccines / Q000008:administration & dosage* / Q000235:genetics / Q000276:immunology*; D013154:Spleen / Q000166:cytology; D013997:Time Factors
chemical_list: D000276:Adjuvants, Immunologic; D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D002412:Cations; D016207:Cytokines; D007074:Immunoglobulin G; D008081:Liposomes; D016052:Protozoan Vaccines; D008666:Metalloendopeptidases; C055146:glycoprotein gp63, Leishmania